Clinical Trial Update: Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial assessing zoledronic acid to prevent bone loss after bariatric surgery has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Bone Loss
• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bariatric Surgery Candidate | Phase 4 | Status: COMPLETED | Results posted: 2021-04-29